pinktest_usa_2545|HBMK|Short Name|pe_ratio|shareholder_yield_ttm|enterprise_value|cash_on_hand|average_volume_30|one_year_return|price|ps_ratio|market_beta_12_month|total_deposits|dividend_yield|average_shares_outs_diluted|price_next_month|price_second_month
pinktest_usa_2545|HBMK|Long Name|Hubei Minkang Pharmaceutical Ltd PE Ratio|Hubei Minkang Pharmaceutical Ltd Shareholder Yield (TTM)|Hubei Minkang Pharmaceutical Ltd Enterprise Value (USD)|Hubei Minkang Pharmaceutical Ltd Cash and Short Term Investments (Quarterly) (USD)|Hubei Minkang Pharmaceutical Ltd 30-Day Average Daily Volume|Hubei Minkang Pharmaceutical Ltd 1 Year Price Returns (Daily)|Hubei Minkang Pharmaceutical Ltd Price (USD)|Hubei Minkang Pharmaceutical Ltd PS Ratio|Hubei Minkang Pharmaceutical Ltd Beta (1Y)|Hubei Minkang Pharmaceutical Ltd Total Deposits (Quarterly) (USD)|Hubei Minkang Pharmaceutical Ltd Dividend Yield|Hubei Minkang Pharmaceutical Ltd Average Diluted Shares Outstanding (Quarterly)||
pinktest_usa_2545|HBMK|Unit|figure_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_money_USD_price|figure_USD_metric|figure_USD_beta|mil_figure_money_USD_metric|percent_USD_metric|mil_figure_USD_metric||
pinktest_usa_2545|HBMK|200706||||0.0059||||||||16.791||
pinktest_usa_2545|HBMK|200709||||0.4625||||||||16.875||
pinktest_usa_2545|HBMK|200712||||0.4591||||||||16.875||
pinktest_usa_2545|HBMK|200803||||0.008||||||||16.875||
pinktest_usa_2545|HBMK|200806||||0.187||||||||6.875||
pinktest_usa_2545|HBMK|200809||||0.0041||||||||7.0516||
pinktest_usa_2545|HBMK|200812||||0.004||||||||7.0516||
pinktest_usa_2545|HBMK|200903||||0.0036||||||||7.2281||
pinktest_usa_2545|HBMK|200906||||0.0112||||||||7.0516||
pinktest_usa_2545|HBMK|200909||||0.0093||||||||7.0516||
pinktest_usa_2545|HBMK|200912||||0.0081||||||||7.0516||
pinktest_usa_2545|HBMK|201003||||0.0073||||||||7.0516||
pinktest_usa_2545|HBMK|201006||||0.0192||||||||7.0516||
pinktest_usa_2545|HBMK|201009||||0.005||||||||7.3996||
pinktest_usa_2545|HBMK|201012||||0.0126||||||||8.1176||
pinktest_usa_2545|HBMK|201103||||0.0014||||||||8.032||
pinktest_usa_2545|HBMK|201106||||0.0006||||||||8.5941||
pinktest_usa_2545|HBMK|201109||||3.1461||||||||34.4442||
pinktest_usa_2545|HBMK|201112||||3.1048||||||||43.1493||
pinktest_usa_2545|HBMK|201203||||2.9223||||||||43.0472||
pinktest_usa_2545|HBMK|201206||||3.4537||||||||43.6185||
pinktest_usa_2545|HBMK|201209||||3.9954||||||||44.1774||
pinktest_usa_2545|HBMK|201212||||6.0733||||||||44.1806||
pinktest_usa_2545|HBMK|201303||||4.9272||||||||52.189||
pinktest_usa_2545|HBMK|201306||||5.4169||||||||52.189||
pinktest_usa_2545|HBMK|201309||||6.2009||||||||52.189||
pinktest_usa_2545|HBMK|201312||||6.8232||||||||52.189||
pinktest_usa_2545|HBMK|201403||||5.892||||||||52.189||
pinktest_usa_2545|HBMK|201406||||6.2054||||||||52.189||
pinktest_usa_2545|HBMK|201409||||4.7999||||||||52.189||
pinktest_usa_2545|HBMK||||||||||||||0.0008|0.0008
pinktest_usa_2545|HBMK|201812|||-1.5086||||0.0008|0.004|||0||0.0008|0.0008
pinktest_usa_2545|HBMK|201903|||-1.5086||0||0.0008|0.004|||0||0.0008|0.0008
pinktest_usa_2545|HBMK|201906|||17.2377||0||0.36|1.8187|||0||0.36|0.36
pinktest_usa_2545|HBMK|201909|||14.1063||0|37400|0.3|1.5155|-952.285||0||0.3|0.3
pinktest_usa_2545|HBMK|201912|||3.6737||364.8|12412.5|0.1001|0.5057|-2571.4199||0||0.1001|0.1001
pinktest_usa_2545|HBMK|202003|||4.1904||112.5333|13650|0.11|0.5557|-736.9562||0||0.11|0.11
pinktest_usa_2545|HBMK|202006|||-0.5118||8673.3333|-94.4722|0.0199|0.1005|0.0369||0||0.0199|0.0199
pinktest_usa_2545|HBMK|202009|||-1.0285||503.3333|-96.6667|0.01|0.0505|0.1678||0||0.01|0.01